ArticleFrontiers in molecular biosciences2021

Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.

Zengyu Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.